Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
50.47 CAD | +4.02% | +0.70% | -21.19% |
May. 13 | Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating | MT |
May. 10 | National Bank Reviews Docebo's Q1 -- Trims Target to US$55 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.19% | 1.08B | |
+14.09% | 3,197B | |
+14.08% | 89.6B | |
+8.28% | 80.08B | |
-13.37% | 55.52B | |
+22.66% | 46.79B | |
+32.09% | 46.34B | |
-30.84% | 43.95B | |
+71.04% | 41.34B | |
-3.03% | 26.5B |
- Stock Market
- Equities
- DCBO Stock
- News Docebo Inc.
- Docebo Maintained at Buy at Stifel GMP Following C-Suite Changes; Price Target Raised to US$60.00